These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Experimental studies on the serum therapy of type E botulism: the relationship between the amount of toxin in the blood and the effect of antitoxic serum. Iida H; Ono T; Karashimada T Jpn J Med Sci Biol; 1970 Oct; 23(5):344-7. PubMed ID: 4993667 [No Abstract] [Full Text] [Related]
27. Isolation, activity, and physicochemical characterization of a burn toxin from mouse skin. Schoenenberger GA; Allgöwer M Br J Surg; 1969 Sep; 56(9):704. PubMed ID: 5808420 [No Abstract] [Full Text] [Related]
29. An inhibitor of toxin lethality: "competitin". Rosenthal SR; Thadhani KC; Spurrier WA Exp Med Surg; 1968 Mar; 26(3):124-30. PubMed ID: 5735314 [No Abstract] [Full Text] [Related]
30. Formation of a specific 'burn toxin' in mouse skin by thermal injuries. Experimental results. Städtler K; Allgöwer M; Cueni LB; Schoenenberger GA Eur Surg Res; 1972; 4(3):198-210. PubMed ID: 5071271 [No Abstract] [Full Text] [Related]
31. [Experimental observations on burn toxins]. ALLGOWER M; ASCHIERI F; HULLIGER L Ann Chir Plast; 1961 Sep; 6():203-9. PubMed ID: 13860604 [No Abstract] [Full Text] [Related]
32. [Studies on Clostridium botulinum type F. II. Isolation of highly active toxin and its properties]. Rymkiewicz D Med Dosw Mikrobiol; 1968; 20(3):281-7. PubMed ID: 4884893 [No Abstract] [Full Text] [Related]
33. Isolation, biological and antigenic properties of a specific toxin formed in thermally altered mouse skin. Schoenenberger GA; Allgöwer M; Cueni LB; Eppenberger U; Städtler KE Eur J Clin Invest; 1972 Mar; 2(3):154-62. PubMed ID: 5038804 [No Abstract] [Full Text] [Related]
34. [Transmission and scanning electron microscopy studies of a specific burn toxin and its effect on the mouse liver following sublethal burns]. Kremer B; Frenzel H; Allgöwer M; Städtler K; Schoenenberger GA Verh Dtsch Ges Pathol; 1975; 59():581. PubMed ID: 1217146 [No Abstract] [Full Text] [Related]
35. [Content of middle mass molecules in blood serum of patients with burns after hemosorption treatment]. Markelov IM; Vikhriev BS; Tupikova ZA; Kuznetsova LA Vopr Med Khim; 1983; 29(3):105-8. PubMed ID: 6880111 [TBL] [Abstract][Full Text] [Related]
36. [Pathogenesis of burn autointoxication]. Fedorov NA Vestn Akad Med Nauk SSSR; 1979; (3):33-40. PubMed ID: 442794 [No Abstract] [Full Text] [Related]
37. [Preparation and evaluation of a standard botulinum A antitoxin and a botulinum A test toxin]. Windler D; Patzwaldt HG; Friedemann J Pharmazie; 1971 May; 26(5):306-8. PubMed ID: 4935133 [No Abstract] [Full Text] [Related]
38. Purified burn toxic factor and its competitin. Rosenthal SR; Hawley PL; Hakim AA Surgery; 1972 Apr; 71(4):527-36. PubMed ID: 5021069 [No Abstract] [Full Text] [Related]
39. Studies on isolation of a toxic substance from human and animal skin burned in vitro. Kwiek S; Kubica J; Rysińska A; Grzybowski J; Witecki J; Bukowska B Arch Immunol Ther Exp (Warsz); 1981; 29(1):69-77. PubMed ID: 7283679 [TBL] [Abstract][Full Text] [Related]